JP2010526102A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010526102A5 JP2010526102A5 JP2010506692A JP2010506692A JP2010526102A5 JP 2010526102 A5 JP2010526102 A5 JP 2010526102A5 JP 2010506692 A JP2010506692 A JP 2010506692A JP 2010506692 A JP2010506692 A JP 2010506692A JP 2010526102 A5 JP2010526102 A5 JP 2010526102A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- hydrochloride
- bernakalant
- mammal
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *c1c(*)cc(CCOC(CCCC2)C2N(CC2)CC2O)cc1 Chemical compound *c1c(*)cc(CCOC(CCCC2)C2N(CC2)CC2O)cc1 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91612907P | 2007-05-04 | 2007-05-04 | |
| US6615607P | 2007-08-01 | 2007-08-01 | |
| US3411908P | 2008-03-05 | 2008-03-05 | |
| US3719808P | 2008-03-17 | 2008-03-17 | |
| PCT/US2008/062551 WO2008137778A2 (en) | 2007-05-04 | 2008-05-02 | Controlled release oral formulations of ion channel modulating compounds and related methods for preventing arrhythmia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010526102A JP2010526102A (ja) | 2010-07-29 |
| JP2010526102A5 true JP2010526102A5 (enExample) | 2011-06-23 |
Family
ID=39691347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010506692A Pending JP2010526102A (ja) | 2007-05-04 | 2008-05-02 | イオンチャネル調節化合物の制御放出経口製剤および不整脈を予防するための関連する方法 |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US20080312309A1 (enExample) |
| EP (3) | EP2462933A1 (enExample) |
| JP (1) | JP2010526102A (enExample) |
| KR (1) | KR20100017648A (enExample) |
| CN (1) | CN101711174A (enExample) |
| AU (1) | AU2008247508B2 (enExample) |
| BR (1) | BRPI0810697A2 (enExample) |
| CA (1) | CA2686396A1 (enExample) |
| CO (1) | CO6241136A2 (enExample) |
| CR (1) | CR11117A (enExample) |
| EA (1) | EA200971025A1 (enExample) |
| EC (1) | ECSP099777A (enExample) |
| IL (1) | IL201934A0 (enExample) |
| MA (1) | MA31664B1 (enExample) |
| MX (1) | MX2009011929A (enExample) |
| NI (1) | NI200900196A (enExample) |
| NZ (1) | NZ581351A (enExample) |
| TN (1) | TN2009000461A1 (enExample) |
| WO (1) | WO2008137778A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090041841A1 (en) * | 2003-05-02 | 2009-02-12 | Cardiome Pharma Corp. | Controlled release tablet formulations for the prevention of arrhythmias |
| US7345086B2 (en) * | 2003-05-02 | 2008-03-18 | Cardiome Pharma Corp. | Uses of ion channel modulating compounds |
| WO2011103398A1 (en) * | 2010-02-18 | 2011-08-25 | Aegis Sciences Corporation | Detection and quantitation of pain medications in oral fluid specimens |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0463395B1 (en) | 1990-06-22 | 1997-05-14 | F. Hoffmann-La Roche Ag | Detection of poor metabolizers of drugs |
| US5891696A (en) | 1996-08-02 | 1999-04-06 | Panvera Corporation | Compositions for cytochrome P450 biotransformation reactions |
| JP3176342B2 (ja) | 1997-08-13 | 2001-06-18 | ファイザー製薬株式会社 | 薬剤代謝の評価方法及び前記方法用の試薬組成物 |
| EP1422217A3 (en) * | 1998-04-01 | 2004-06-16 | Cardiome Pharma Corp. | Aminocyclohexyl ether compounds and uses thereof |
| US7507545B2 (en) * | 1999-03-31 | 2009-03-24 | Cardiome Pharma Corp. | Ion channel modulating activity method |
| US7057053B2 (en) * | 2000-10-06 | 2006-06-06 | Cardiome Pharma Corp. | Ion channel modulating compounds and uses thereof |
| US7524879B2 (en) * | 2000-10-06 | 2009-04-28 | Cardiome Pharma Corp. | Ion channel modulating compounds and uses thereof |
| EP1281755A3 (en) | 2001-07-31 | 2003-06-18 | Pfizer Products Inc. | Variants of the human cyp2d6 gene |
| US7148226B2 (en) | 2003-02-21 | 2006-12-12 | Agouron Pharmaceuticals, Inc. | Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| US20080063707A1 (en) * | 2003-05-02 | 2008-03-13 | Cardiome Pharma Corp. | Controlled release tablet formulations for the prevention of arrhythmias |
| KR101059379B1 (ko) * | 2003-05-02 | 2011-08-26 | 카디오메 파마 코포레이션 | 아미노사이클로헥실 에테르 화합물, 이의 제조방법 및 이를 포함하는 약제학적 조성물 |
| WO2004098525A2 (en) * | 2003-05-02 | 2004-11-18 | Cardiome Pharma Corp. | Uses of ion channel modulating compounds |
| US7345086B2 (en) * | 2003-05-02 | 2008-03-18 | Cardiome Pharma Corp. | Uses of ion channel modulating compounds |
| US20090041841A1 (en) * | 2003-05-02 | 2009-02-12 | Cardiome Pharma Corp. | Controlled release tablet formulations for the prevention of arrhythmias |
| US7674820B2 (en) * | 2003-08-07 | 2010-03-09 | Cardiome Pharma Corp. | Ion channel modulating activity I |
| US7345087B2 (en) | 2003-10-31 | 2008-03-18 | Cardiome Pharma Corp. | Aminocyclohexyl ether compounds and uses thereof |
| US7705036B2 (en) * | 2004-04-01 | 2010-04-27 | Cardiome Pharma Corp. | Deuterated aminocyclohexyl ether compounds and processes for preparing same |
| WO2006138673A2 (en) * | 2005-06-15 | 2006-12-28 | Cardiome Pharma Corp. | Synthetic processes for the preparation of aminocyclohexyl ether compounds |
| US8263638B2 (en) * | 2004-11-08 | 2012-09-11 | Cardiome Pharma Corp. | Dosing regimens for ion channel modulating compounds |
| WO2009018547A1 (en) * | 2007-08-01 | 2009-02-05 | Cardiome Pharma Corp. | Extended release formulations containing an ion-channel-modulating compound for the prevention of arrhythmias |
-
2008
- 2008-05-02 JP JP2010506692A patent/JP2010526102A/ja active Pending
- 2008-05-02 EP EP12001273A patent/EP2462933A1/en not_active Withdrawn
- 2008-05-02 US US12/114,652 patent/US20080312309A1/en not_active Abandoned
- 2008-05-02 EP EP12001278A patent/EP2468278A1/en not_active Withdrawn
- 2008-05-02 MX MX2009011929A patent/MX2009011929A/es not_active Application Discontinuation
- 2008-05-02 CA CA002686396A patent/CA2686396A1/en not_active Abandoned
- 2008-05-02 CN CN200880021022A patent/CN101711174A/zh active Pending
- 2008-05-02 WO PCT/US2008/062551 patent/WO2008137778A2/en not_active Ceased
- 2008-05-02 EP EP08755034A patent/EP2155334A2/en not_active Withdrawn
- 2008-05-02 EA EA200971025A patent/EA200971025A1/ru unknown
- 2008-05-02 AU AU2008247508A patent/AU2008247508B2/en not_active Ceased
- 2008-05-02 BR BRPI0810697A patent/BRPI0810697A2/pt not_active IP Right Cessation
- 2008-05-02 KR KR1020097025421A patent/KR20100017648A/ko not_active Withdrawn
- 2008-05-02 NZ NZ581351A patent/NZ581351A/en not_active IP Right Cessation
-
2009
- 2009-11-04 TN TNP2009000461A patent/TN2009000461A1/fr unknown
- 2009-11-04 IL IL201934A patent/IL201934A0/en unknown
- 2009-11-04 NI NI200900196A patent/NI200900196A/es unknown
- 2009-11-18 CR CR11117A patent/CR11117A/es unknown
- 2009-11-26 MA MA32379A patent/MA31664B1/fr unknown
- 2009-12-02 CO CO09137710A patent/CO6241136A2/es not_active Application Discontinuation
- 2009-12-02 EC EC2009009777A patent/ECSP099777A/es unknown
-
2014
- 2014-06-17 US US14/306,915 patent/US20150099788A1/en not_active Abandoned
-
2015
- 2015-12-02 US US14/957,109 patent/US20160089361A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL179454A (en) | Coated tablet formulation comprising saxagliptin and method for preparing the same | |
| JP2008501025A5 (enExample) | ||
| ZA200706192B (en) | Pharmaceutical composition comprising an indolyl-maleimide derivative | |
| US20040186122A1 (en) | Method of treating acute pain with a unitary dosage form comprising ibuprofin and oxycodone | |
| EP3781135A2 (en) | Solid oral pharmaceutical compositions comprising sitagliptin | |
| Siddiqui et al. | Ranolazine: a review of its use in chronic stable angina pectoris | |
| EP4008317A1 (en) | Solid pharmaceutical formulations of amorphous dapagliflozin | |
| EP3955910A1 (en) | Sustained release formulations | |
| CN1649569A (zh) | 控释剂型 | |
| CA3185535A1 (en) | The process for the preparation of a film coated tablet comprising linagliptin and metformin | |
| EP2867199B1 (en) | Stable compositions of fesoterodine | |
| US20140010883A1 (en) | Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor | |
| US20230172863A1 (en) | Modified-release dosage forms of ruxolitinib | |
| WO2022225489A1 (en) | A bilayer tablet formulation comprising amorphous dapagliflozin and metformin | |
| CA3085455A1 (en) | A solid oral dosage form comprising linagliptin | |
| US20130189358A1 (en) | Saxagliptin pharmaceutical formulations | |
| WO2007049868A1 (en) | Stabilized pharmaceutical oral preparation containing clopidogrel bisulfate | |
| WO2017175855A1 (en) | Stabilized solid dosage form | |
| US20090018181A1 (en) | Drug composition for prevention or inhibition of advance of diabetic complication | |
| US20130251795A1 (en) | Pharmaceutical compositions containing a biguanide and a low dose antidiabetic agent | |
| US20250221937A1 (en) | Stable pharmaceutical compositions comprising erdafitinib | |
| US20100081702A1 (en) | Pharmaceutical composition for prophylaxis or treatment of hepatitis | |
| WO2009080762A2 (en) | Pharmaceutical composition | |
| TR2025007041A2 (tr) | Li̇nagli̇pti̇n ve metformi̇n i̇çeren farmasöti̇k uzatilmiş salim formülasyonlari | |
| RU2020143179A (ru) | Фармацевтическая комбинация, композиция и состав, содержащие активатор глюкокиназы и ингибитор альфа-глюкозидазы, способы приготовления и их применение |